The largest database of trusted experimental protocols

4 protocols using multiflo fx multi mode dispenser

1

High-throughput screening of antibiotic-resistant bacteria

Check if the same lab product or an alternative is used in the 5 most similar protocols
Compounds from the 10 mM ReFRAME library stock 14 (link) were acoustically transferred using the Echo 555 Liquid Handler (Labcyte Inc.) at 20 μM final assay concentration into 1536-well plates. Log-phase growth A. baumannii HUMC1 was diluted in assay media (MHII or RPMI with and without 50% normal mouse serum) and dispensed into assay plates using the MultiFlo FX Multi-Mode Dispenser (BioTek). Bacterial viability was assessed 24 hours later using the BacTiter-Glo Microbial Cell Viability Assay (Promega) and the PHERAstar microplate reader (BMG Labtech). Positive controls included 10 μM colistin and doxycycline. Assay was normalized to neutral and positive controls and putative hits were selected based on 50% reduction in viability. Putative hits were re-tested in single point triplicate and upon reconfirmation were further tested in an 8-point 1:3 dose response and counter-screened against mammalian HepG2 and HEK293T cell lines using a 72-hour CellTiter-Glo Luminescent Cell Viability Assay (Promega). For the mammalian cytotoxicity counter screen 40 μM puromycin (Sigma) was used as the positive control and data was normalized as for the primary assay. All data were uploaded to and analyzed in Genedata Screener, Version 13.0.1-Standard. Replicate data were analyzed using median condensing. Dose response curves were fitted with the four parameter Hill Equation.
+ Open protocol
+ Expand
2

High-Throughput Cancer Drug Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in 384-well plates at 1,000 cells/well in 40 µL of growth medium. After 24 hours, cells were treated with varied concentrations of drugs from a small Food and Drug Administration (FDA)-approved cancer drug library consisting of 62 cancer drugs (purchased from Selleck Chemicals or MedChemExpress) with 28 specific targeted molecules for 5 days. Cell numbers were determined by the Operetta® High Content Screening System (PerkinElmer, Waltham, MA, USA). The images were used to calculate growth rate inhibition (GR) values using the following equation (18 (link)).
For high-throughput drug screening, cells were seeded in 384-well plates using a MultiFlo FX Multimode Dispenser (BioTek Instruments, Winooski, VT, USA) at 1,000 cells/well in 40 µl of growth medium. After 24 hours, cells were treated with the drugs in the drug library (at their respective GR75 values) in 20 µl of the total growth medium and using an EpMotion pipetting robot (Eppendorf, Hamburg, Germany). The cells were incubated for 5 days in a 37°C 5% CO2 environment. Cells were stained with 4,6-diamidino-2-phenylindole (DAPI) and imaged using an Operetta CLS™ high-content system (PerkinElmer). The nuclei number was analyzed using a Columbus Image Data Storage and Analysis System (PerkinElmer), and plotted using MATLAB 2017a software (MathWorks, Natick, MA, USA).
+ Open protocol
+ Expand
3

Cell Viability Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proliferating cells were seeded at approximately 20 × 103 cells per 50 μL per well into 96 well plates using a MultiFlo FX multimode dispenser (BioTek). On reaching ~40% cell density, the cells were then incubated with varying concentrations (195 nM to 200 μM final) of test samples using a Biomek FXP Automated Workstation (Beckman Coulter). 48 hours post drug incubation, cell viability was determined using Promega’s CellTiter-Glo Luminescent Cell Viability Assay according to the manufacturer’s protocol on a plate reader (EnVision from PerkinElmer) in Luminescence mode. In each experiment, each unique condition (i.e., different sample type and concentration) was tested in triplicate. The percentage of test sample induced toxicity was calculated with respect to DMSO treated cells, and graphed to give dose response curves. IC50 values for each treatment were calculated using GraphPad Prism 8.0 Software.
+ Open protocol
+ Expand
4

High-throughput screening of antibiotic-resistant bacteria

Check if the same lab product or an alternative is used in the 5 most similar protocols
Compounds from the 10 mM ReFRAME library stock 14 (link) were acoustically transferred using the Echo 555 Liquid Handler (Labcyte Inc.) at 20 μM final assay concentration into 1536-well plates. Log-phase growth A. baumannii HUMC1 was diluted in assay media (MHII or RPMI with and without 50% normal mouse serum) and dispensed into assay plates using the MultiFlo FX Multi-Mode Dispenser (BioTek). Bacterial viability was assessed 24 hours later using the BacTiter-Glo Microbial Cell Viability Assay (Promega) and the PHERAstar microplate reader (BMG Labtech). Positive controls included 10 μM colistin and doxycycline. Assay was normalized to neutral and positive controls and putative hits were selected based on 50% reduction in viability. Putative hits were re-tested in single point triplicate and upon reconfirmation were further tested in an 8-point 1:3 dose response and counter-screened against mammalian HepG2 and HEK293T cell lines using a 72-hour CellTiter-Glo Luminescent Cell Viability Assay (Promega). For the mammalian cytotoxicity counter screen 40 μM puromycin (Sigma) was used as the positive control and data was normalized as for the primary assay. All data were uploaded to and analyzed in Genedata Screener, Version 13.0.1-Standard. Replicate data were analyzed using median condensing. Dose response curves were fitted with the four parameter Hill Equation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!